Analysis of the phosphatidylinositol 3′-kinase signaling pathway in glioblastoma patients in vivo

Cancer Research

Volumn 63, Issue 11, 2003, Pages 2742-2746

  Choe, Gheeyoung ^a   Horvath, Steve ^a   Cloughesy, Timothy F ^a   Crosby, Katherine ^c   Seligson, David ^a   Palotie, Aarno ^a,b   Inge, Landon ^a   Smith, Bradley L ^c   Sawyers, Charles L ^a   Mischel, Paul S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

^c CELL SIGNALING TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MAMMALIAN TARGET OF RAPAMYCIN; MUTANT PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN; PROTEIN KINASE B; S6 KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR FOXO4; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVATION; ENZYME ANALYSIS; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BRAIN NEOPLASMS; DNA-BINDING PROTEINS; ENZYME ACTIVATION; FORKHEAD TRANSCRIPTION FACTORS; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; LOGISTIC MODELS; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0038615946     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Vivanco, I., and Sawyers, C. L. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat. Rev. Cancer, 2: 489-501, 2002.
2. Sawyers, C. L. Rational therapeutic intervention in cancer: kinases as drug targets. Curr. Opin. Genet. Dev., 12: 111-115, 2002.
3. Neshat, M. S., Mellinghoff, I. K., Tran, C., Stiles, B., Thomas, G., Petersen, R., Frost, P., Gibbons, J. J., Wu, H., and Sawyers, C. L. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR. Proc. Natl. Acad. Sci. USA, 98: 10314-10319, 2001.
4. Hidalgo, M., and Rowinsky, E. K. The rapamycin-sensitive signal transduction cascade as a target for cancer therapy. Oncogene, 19: 6680-6686, 2000.
5. Druker, B. J. Perspectives on the development of a molecularly targeted agent. Cancer Cell, 1: 31-36, 2002.
6. Blume-Jensen, P., and Hunter, T. Oncogenic kinase signaling. Nature (Lond.), 411: 355-365, 2001.
7. Mischel, P. S., and Cloughesy, T. F. Targeted molecular therapy of glioblastoma. Brain Pathol., 13: 52-61, 2003.
8. Ermoian, R. P., Furniss, C. S., Lamborn, K. R., Basila, D., Berger, M. S., Gottschalk, A. R., Nicholas, M. K., Stokoe, D., and Haas-Kogan, D. A. Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survival. Clin. Cancer Res., 8: 1100-1106, 2002.
9. Davies, M. A., Lu, Y., Sano, T., Fang, X., Tang, P., LaPushin, R., Koul, D., Bookstein, R., Stokoe, D., Yung, W. K., Mills, G. B., and Steck, P. A. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis. Cancer Res., 58: 5285-5290, 1998.
10. Gimm, O., Perren, A., Weng, L. P., Marsh, D. J., Yeh, J. J., Ziebold, U., Gil, E., Hinze, R., Delbridge, L., Lees, J. A., Mutter, G. L., Robinson, B. G., Komminoth, P., Dralle, H., and Eng, C. Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors. Am. J. Pathol., 156: 1693-1700, 2000.
11. Perren, A., Komminoth, P., Saremaslani, P., Matter, C., Feurer, S., Lees, J. A., Heitz, P. U., and Eng, C. Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells. Am. J. Pathol., 157: 1097-1103, 2000.
12. Perren, A., Weng, L. P., Boag, A. H., Ziebold, U., Thakore, K., Dahia, P. L., Komminoth, P., Lees, J. A., Mulligan, L. M., Mutter, G. L., and Eng, C. Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast. Am. J. Pathol., 155: 1253-1260, 1999.
13. Zhou, X. P., Gimm, O., Hampel, H., Niemann, T., Walker, M. J., and Eng, C. Epigenetic PTEN silencing in malignant melanomas without PTEN mutation. Am. J. Pathol., 157: 1123-1128, 2000.
14. Wikstrand, C. J., Hale, L. P., Batra, S. K., Hill, M. L., Humphrey, P. A., Kurpad, S. N., McLendon, R. E., Moscatello, D., Pegram, C. N., Reist, C. J., et al. Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. Cancer Res., 55: 3140-3148, 1995.
15. Ihaka, R., and Gentleman, R. R: a language for data analysis and graphics. J. Comput. Graphical Statistics, 5: 299-314, 1996.
16. Cox, T. F., and Cox, M. A. A. Multidimensional Scaling. United Kingdom: CRC Press, 2001.
17. Burgering, B. M., and Kops, G. J. Cell cycle and death control: long live Forkheads. Trends Biochem. Sci., 27: 352-360, 2002.
18. Nagane, M., Lin, H., Cavenee, W. K., and Huang, H. J. Aberrant receptor signaling in human malignant gliomas: mechanisms and therapeutic implications. Cancer Lett., 162 (Suppl.): S17-S21, 2001.
19. Ekstrand, A. J., Sugawa, N., James, C. D., and Collins, V. P. Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. Proc. Natl. Acad. Sci. USA, 89: 4309-4313, 1992.
20. Liu, W., James, C. D., Frederick, L., Alderete, B. E., and Jenkins, R. B. PTEN/MMACl mutations and EGFR amplification in glioblastomas. Cancer Res., 57: 5254-5257, 1997.
21. Venables, W. N., and Ripley, B. D. Modern Applied Statistic with S-Plus. New York: Springer, 1999.
22. Holland, E. C., Celestino, J., Dai, C., Schaefer, L., Sawaya, R. E., and Fuller, G. N. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat. Genet., 25: 55-57, 2000.